Physiological healing of chronic gastric ulcer is not impaired by the hydrogen sulphide (H2S)-releasing derivative of acetylsalicylic acid (ATB-340): functional and proteomic approaches

Edyta Korbut,Maciej Suski,Zbigniew Śliwowski,Dominik Bakalarz,Urszula Głowacka,Dagmara Wójcik-Grzybek,Grzegorz Ginter,Kinga Krukowska,Tomasz Brzozowski,Marcin Magierowski,John L. Wallace,Katarzyna Magierowska
DOI: https://doi.org/10.1007/s10787-024-01458-3
2024-04-05
Inflammopharmacology
Abstract:Gastric ulcers affect approx. 10% of population. Non-steroidal anti-inflammatory drugs (NSAIDs), including acetylsalicylic acid (ASA) predispose to or impair the physiologically complex healing of pre-existing ulcers. Since H 2 S is an endogenous cytoprotective molecule, we hypothesized that new H 2 S-releasing ASA-derivative (ATB-340) could overcome pathological impact of NSAIDs on GI regeneration.
immunology,toxicology
What problem does this paper attempt to address?